The test is designed for people aged 45 years and above who are at average colorectal cancer risk. Credit: aslysun / Shutterstock.com. · Medical Device Network · aslysun / Shutterstock.com. The US ...
Geneoscopy is poised to commercialize Colosense, its noninvasive, at-home multitarget stool RNA test for colorectal cancer screening. In 2025, the St. Louis, MO-based life sciences company focused on ...
ST. LOUIS--(BUSINESS WIRE)--Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, announced the publication of a ...
With colorectal cancer a growing concern among younger people, the American Cancer Society has endorsed two new types of stool tests to encourage people to get screened, while also recommending a ...
Two-step screen + RT-qPCR validation yields AUC 0.94 (CRC) and 0.83 (advanced adenoma) in 114-sample pilot PLEASANTON, Calif., Aug. 25, 2025 /PRNewswire/ -- A peer-reviewed study published in ...
Newswise — The American Cancer Society (ACS) today released updated guidelines for colorectal cancer screening. The new recommendations reaffirm that average-risk adults should begin colorectal cancer ...
A study has used advanced genetic and genomic techniques to offer a major step forward in understanding and diagnosing infectious intestinal diseases. The large-scale study analyzed more than 1,000 ...
When Erica Barnell was an MD/PhD student at Washington University in St. Louis, she met a woman who had stage four colorectal cancer (CRC). The woman was only 52 years old—more than a decade younger ...
A new liquid biopsy developed by researchers at the University of Chicago is offering a powerful new window into cancer’s earliest stages by flagging subtle shifts in the gut microbiome. Unlike ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results